Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea, Immune-mediated cholangitis: is it always nivolumab’s fault?, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2018, 67, pp. 1325 - 1327 [articolo]
Tiseo, Marcello*; Boni, Luca; Ardizzoni, Andrea, Is the door open to further investigation with antiangiogenesis in SCLC?, «JOURNAL OF THORACIC DISEASE», 2018, 10, pp. S1127 - S1128 [articolo]
Ghedini, Pietro*; Bossert, I.; Zanoni, L.; Ceci, F.; Graziani, T.; Castellucci, P.; Ambrosini, V.; Massari, F.; Nobili, E.; Melotti, B.; Musto, A.; Zoboli, S.; Antunovic, L.; Kirienko, M.; Chiti, A.; Mosconi, C.; Ardizzoni, A.; Golfieri, R.; Fanti, S.; Nanni, C., Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2018, 45, pp. 751 - 758 [articolo]
Mazzaschi, Giulia; Madeddu, Denise; Falco, Angela; Bocchialini, Giovanni; Goldoni, Matteo; Sogni, Francesco; Armani, Giovanna; Lagrasta, Costanza Annamaria; Lorusso, Bruno; Mangiaracina, Chiara; Vilella, Rocchina; Frati, Caterina; Alfieri, Roberta; Ampollini, Luca; Veneziani, Michele; Silini, Enrico Maria; Ardizzoni, Andrea; Urbanek, Konrad; Aversa, Franco; Quaini, Federico*; Tiseo, Marcello, Low PD-1 expression in cytotoxic CD8þtumor-Infiltrating lymphocytes confers an immune-privileged tissue microenvironment in NSCLC with a prognostic and predictive value, «CLINICAL CANCER RESEARCH», 2018, 24, pp. 407 - 419 [articolo]
Garassino, Marina Chiara; Crinò, Lucio; Catino, Annamaria; Ardizzoni, Andrea; Cortesi, Enrico; Cappuzzo, Federico; Bordi, Paola; Calabrò, Luana; Barbieri, Fausto; Santo, Antonio; Altavilla, Giuseppe; Ambrosio, Francesca; Mini, Enrico; Vasile, Enrico; Morgillo, Floriana; Scoppola, Alessandro; Bengala, Carmelo; Follador, Alessandro; Tedde, Natale; Giannarelli, Diana; Lo Russo, Giuseppe*; Vitiello, Fabiana, Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program, «TUMOR BIOLOGY», 2018, 40, pp. 1 - 8 [articolo]Open Access
Comito, Francesca; Ambrosini, Valentina; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma, «ANTI-CANCER DRUGS», 2018, 29, pp. 1026 - 1029 [articolo]
Gelsomino, F.; Fiorentino, M.*; Zompatori, M.; Poerio, A.; Melotti, B.; Sperandi, F.; Gargiulo, M.; Borghi, C.; Ardizzoni, A., Programmed death-1 inhibition and atherosclerosis: Can nivolumab vanish complicated atheromatous plaques?, «ANNALS OF ONCOLOGY», 2018, 29, Article number: mdx718, pp. 284 - 285 [articolo]
Massari F.; Di Nunno V.; Ardizzoni A., Re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62–8, «EUROPEAN UROLOGY», 2018, 73, pp. 72 - 72 [articolo]
Massari F, Di Nunno V, Gatto L, Santoni M, Schiavina R, Cosmai L, Brunocilla E, Ardizzoni A, Porta C, Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy., «TARGETED ONCOLOGY», 2018, 13, pp. 705 - 714 [articolo]
Massari, Francesco; Ciccarese, Chiara; Hes, Ondrej; Michal, Michal; Caliò, Anna; Fiorentino, Michelangelo; Giunchi, Francesca; D'Amuri, Alessandro; Sanguedolce, Francesca; Sabbatini, Roberto; Guida, Annalisa; Ardizzoni, Andrea; Porta, Camillo; Iacovelli, Roberto; Tortora, Giampaolo; Cima, Luca; Ortega, Cinzia; Lapini, Alberto; Martignoni, Guido; Brunelli, Matteo, The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome, «PATHOLOGY ONCOLOGY RESEARCH», 2018, 24, pp. 447 - 456 [articolo]
Massari, Francesco; Ciccarese, Chiara; Hes, Ondrej; Michal, Michal; Caliò, Anna; Fiorentino, Michelangelo; Giunchi, Francesca; D’Amuri, Alessandro; Sanguedolce, Francesca; Sabbatini, Roberto; Guida, Annalisa; Ardizzoni, Andrea; Porta, Camillo; Iacovelli, Roberto; Tortora, Giampaolo; Cima, Luca; Ortega, Cinzia; Lapini, Alberto; Martignoni, Guido; Brunelli, Matteo*, The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome, «PATHOLOGY ONCOLOGY RESEARCH», 2018, 24, pp. 447 - 456 [articolo]
Capizzi, Elisa; Ricci, Costantino; Giunchi, Francesca; Zagnoni, Stefano; Ceccarelli, Claudio; Gómez, Begoña Urrios Álvarez; Casolari, Laura; Gelsomino, Francesco; Trisolini, Rocco; Fiorentino, Michelangelo*; Ardizzoni, Andrea, Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer, «LUNG CANCER», 2018, 126, pp. 9 - 14 [articolo]Open Access
Cho, Byoung Chul*; Kim, Dong-Wan; Bearz, Alessandra; Laurie, Scott A.; McKeage, Mark; Borra, Gloria; Park, Keunchil; Kim, Sang-We; Ghosn, Marwan; Ardizzoni, Andrea; Maiello, Evaristo; Greystoke, Alastair; Yu, Richard; Osborne, Karen; Gu, Wen; Scott, Jeffrey W.; Passos, Vanessa Q.; Lau, Yvonne Y.; Wrona, Anna, ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic NonâSmall Cell Lung Cancer (NSCLC), «JOURNAL OF THORACIC ONCOLOGY», 2017, 12, pp. 1357 - 1367 [articolo]
Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni, Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo, Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer, «UROLOGIC ONCOLOGY», 2017, 35, pp. 541 - 541.e13 [articolo]
Eusebi, Leonardo Henry; Ceccarelli, Claudio; Artesiani, Maria Laura; Montanaro, Lorenzo; Derenzini, Massimo; Dall'Olio, Filippo; Ardizzoni, Andrea; Biasco, Guido; Adua, Daniela; Bazzoli, Franco; Ricciardiello, Luigi, CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS, in: Gastroenterology, 2017, 152, pp. S550 - S550 (atti di: Digestive Disease Week, Chicago, USA, MAY 06-09, 2017) [Contributo in Atti di convegno]
